Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05853978 · ClinicalTrials.gov registry record · Phase 4
The Evaluation of Balanced Salt Solution During Cataract Surgery
A Phase 4 study of Cataract and Fuchs Dystrophy, sponsored by Adam Fedyk, MD, FACS.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT05853978 is a Phase 4 study of Cataract and Fuchs Dystrophy that has completed, run by Adam Fedyk, MD, FACS. The registered enrollment target is 26 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05853978, a Phase 4 study of Cataract and Fuchs Dystrophy, has completed, sponsored by Adam Fedyk, MD, FACS.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to identify if the use of BSS PLUS® Sterile Intraocular Irrigating Solution as an irrigation solution leads to improved corneal outcomes vs BSS® Sterile Irrigating Solution in more compromised corneas.
Conditions Studied
Interventions
- DRUG BSS Plus
- DRUG BSS
Study Locations (1)
Missouri
- St. Louis Eye Institute - Town and Country
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-04-17 |
| Est. Completion | 2025-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05853978
The ClinicalTrials.gov registry entry for NCT05853978 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (89% lower). The listed sponsor is Adam Fedyk, MD, FACS, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which BSS Plus is the first listed.
NCT05853978 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05853978 about?
NCT05853978 is a clinical study titled "The Evaluation of Balanced Salt Solution During Cataract Surgery". This study aims to identify if the use of BSS PLUS® Sterile Intraocular Irrigating Solution as an irrigation solution leads to improved corneal outcomes vs BSS® Sterile Irrigating Solution in more compromised corneas.
What is the current status of trial NCT05853978?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2023-04-17. Estimated completion is 2025-03-31.
What conditions does trial NCT05853978 study?
This clinical trial studies the following conditions: Cataract, Fuchs Dystrophy.
What interventions are being tested in trial NCT05853978?
The interventions under investigation include: BSS Plus (DRUG), BSS (DRUG).
Who is sponsoring clinical trial NCT05853978?
This trial is sponsored by Adam Fedyk, MD, FACS, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05853978 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.